MAP2K7 and thyroid cancer: In thyroid cancer, the fact that activating BRAF and NRAS mutations are associated with immune changes in opposite directions, despite a common ability to activate the RAS/RAF/MEK/ERK pathway, may be another example where our analysis is identifying tumor subtypes rather than identifying cause-effect relationships.